|
JP3866809B2
(ja)
*
|
1996-12-19 |
2007-01-10 |
松下電器産業株式会社 |
有機膜及びその製造方法
|
|
US7250534B1
(en)
|
1999-07-27 |
2007-07-31 |
University Of South Florida |
Performance of energy storage devices: potential areas for dendritic chemistry involvement
|
|
US7448258B2
(en)
*
|
1999-10-29 |
2008-11-11 |
Avery Dennison Corporation |
High throughput screening for moisture barrier characteristics of materials
|
|
EP1326892A2
(en)
|
2000-10-12 |
2003-07-16 |
University of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
US20020146684A1
(en)
*
|
2001-04-09 |
2002-10-10 |
Meldal Morten Peter |
One dimensional unichemo protection (UCP) in organic synthesis
|
|
DE10158149A1
(de)
*
|
2001-11-28 |
2003-06-18 |
Bayer Ag |
Silangruppen enthaltende Polymere
|
|
JP2005532263A
(ja)
|
2002-02-06 |
2005-10-27 |
ヴァイコー テクノロジーズ， インコーポレイテッド |
抗梗塞分子
|
|
EP1534729A2
(en)
*
|
2002-02-26 |
2005-06-01 |
University of Utah Research Foundation |
Variants of nedd4l associated with hypertension and viral budding
|
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHEMICAL PROTEINS FROM PROTEIN TRANSDUCATING DOMAIN / DEAMINASE, RELATED COMPOUNDS AND THEIR USES
|
|
US20050106068A1
(en)
*
|
2003-11-18 |
2005-05-19 |
Abdul Malik |
Sol-gel dendron separation and extraction capillary column
|
|
JP5129119B2
(ja)
|
2005-04-05 |
2013-01-23 |
コーニング インコーポレイテッド |
標識フリーバイオセンサおよび細胞
|
|
WO2006127020A1
(en)
|
2005-05-19 |
2006-11-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention |
FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF
|
|
US8080534B2
(en)
*
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
EP2395076A1
(en)
|
2005-10-14 |
2011-12-14 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
|
EP1940916B1
(en)
*
|
2005-10-25 |
2016-12-14 |
Starpharma Pty Limited |
Macromolecular compounds having controlled stoichiometry
|
|
US20100190689A1
(en)
|
2006-09-21 |
2010-07-29 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
|
CA2677665C
(en)
|
2007-02-08 |
2019-11-05 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
CA2734322A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
CA2775747A1
(en)
|
2009-10-07 |
2011-04-14 |
Sanford Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
|
EP2512497A1
(en)
|
2009-12-18 |
2012-10-24 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding compounds
|
|
US20140323392A1
(en)
|
2011-03-28 |
2014-10-30 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
WO2019055618A1
(en)
|
2017-09-15 |
2019-03-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
|
|
EP4038222A4
(en)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|